{
    "title": "Research on Human Fetal Tissue Amendments of 1993",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Research on Human Fetal Tissue \nAmendments of 1993''.\n\nSEC. 2. ESTABLISHMENT OF AUTHORITIES AND PROTECTIONS REGARDING \n              TRANSPLANTATION OF HUMAN FETAL TISSUE.\n\n    Part G of title IV of the Public Health Service Act (42 U.S.C. 289 \net seq.) is amended by inserting after section 498 the following new \nsection:\n\n             ``research on transplantation of fetal tissue\n\n    ``Sec. 498A. (a) Establishment of Program.--\n            ``(1) In general.--The Secretary may conduct or support \n        research on the transplantation of human fetal tissue for \n        therapeutic purposes.\n            ``(2) Source of tissue.--Human fetal tissue may be used in \n        research carried out under paragraph (1) regardless of whether \n        the tissue is obtained pursuant to a spontaneous or induced \n        abortion or pursuant to a stillbirth.\n    ``(b) Informed Consent of Donor.--\n            ``(1) In general.--In research carried out under subsection \n        (a), human fetal tissue may be used only if the woman providing \n        the tissue makes a statement, made in writing and signed by the \n        woman, declaring that--\n                    ``(A) the woman donates the fetal tissue for use in \n                research described in subsection (a);\n                    ``(B) the donation is made without any restriction \n                regarding the identity of individuals who may be the \n                recipients of transplantations of the tissue; and\n                    ``(C) the woman has not been informed of the \n                identity of any such individuals.\n            ``(2) Additional statement.--In research carried out under \n        subsection (a), human fetal tissue may be used only if the \n        attending physician with respect to obtaining the tissue from \n        the woman involved makes a statement, made in writing and \n        signed by the physician, declaring that--\n                    ``(A) in the case of tissue obtained pursuant to an \n                induced abortion--\n                            ``(i) the consent of the woman for the \n                        abortion was obtained prior to requesting or \n                        obtaining consent for the tissue to be used in \n                        such research; and\n                            ``(ii) no alteration of the timing, method, \n                        or procedures used to terminate the pregnancy \n                        was made solely for the purposes of obtaining \n                        the tissue;\n                    ``(B) the tissue has been donated by the woman in \n                accordance with paragraph (1); and\n                    ``(C) full disclosure has been provided to the \n                woman with regard to--\n                            ``(i) such physician's interest, if any, in \n                        the research to be conducted with the tissue; \n                        and\n                            ``(ii) any known medical risks to the woman \n                        or risks to her privacy that might be \n                        associated with the donation of the tissue and \n                        that are in addition to risks of such type that \n                        are associated with the woman's medical care.\n    ``(c) Informed Consent of Researcher and Donee.--In research \ncarried out under subsection (a), human fetal tissue may be used only \nif the individual with the principal responsibility for conducting the \nresearch involved makes a statement, made in writing and signed by the \nindividual, declaring that the individual--\n            ``(1) is aware that--\n                    ``(A) the tissue is human fetal tissue;\n                    ``(B) the tissue may have been obtained pursuant to \n                a spontaneous or induced abortion or subsequent to a \n                stillbirth; and\n                    ``(C) the tissue was donated for research purposes;\n            ``(2) has provided such information to other individuals \n        with responsibilities regarding the research;\n            ``(3) will require, prior to obtaining the consent of an \n        individual to be a recipient of a transplantation of the \n        tissue, written acknowledgment of receipt of such information \n        by such recipient; and\n            ``(4) has had no part in any decisions as to the timing, \n        method, or procedures used to terminate the pregnancy made \n        solely for the purposes of the research.\n    ``(d) Availability of Statements for Audit.--\n            ``(1) In general.--In research carried out under subsection \n        (a), human fetal tissue may be used only if the head of the \n        agency or other entity conducting the research involved \n        certifies to the Secretary that the statements required under \n        subsections (b)(2) and (c) will be available for audit by the \n        Secretary.\n            ``(2) Confidentiality of audit.--Any audit conducted by the \n        Secretary pursuant to paragraph (1) shall be conducted in a \n        confidential manner to protect the privacy rights of the \n        individuals and entities involved in such research, including \n        such individuals and entities involved in the donation, \n        transfer, receipt, or transplantation of human fetal tissue. \n        With respect to any material or information obtained pursuant \n        to such audit, the Secretary shall--\n                    ``(A) use such material or information only for the \n                purposes of verifying compliance with the requirements \n                of this section;\n                    ``(B) not disclose or publish such material or \n                information, except where required by Federal law, in \n                which case such material or information shall be coded \n                in a manner such that the identities of such \n                individuals and entities are protected; and\n                    ``(C) not maintain such material or information \n                after completion of such audit, except where necessary \n                for the purposes of such audit.\n    ``(e) Applicability of State and Local Law.--\n            ``(1) Research conducted by recipients of assistance.--The \n        Secretary may not provide support for research under subsection \n        (a) unless the applicant for the financial assistance involved \n        agrees to conduct the research in accordance with applicable \n        State and local law.\n            ``(2) Research conducted by secretary.--The Secretary may \n        conduct research under subsection (a) only in accordance with \n        applicable State and local law.\n    ``(f) Definition.--For purposes of this section, the term `human \nfetal tissue' means tissue or cells obtained from a dead human embryo \nor fetus after a spontaneous or induced abortion, or after a \nstillbirth.''.\n\nSEC. 3. PURCHASE OF HUMAN FETAL TISSUE; SOLICITATION OR ACCEPTANCE OF \n              TISSUE AS DIRECTED DONATION FOR USE IN TRANSPLANTATION.\n\n    Part G of title IV of the Public Health Service Act, as amended by \nsection 2 of this Act, is amended by inserting after section 498A the \nfollowing new section:\n\n              ``prohibitions regarding human fetal tissue\n\n    ``Sec. 498B. (a) Purchase of Tissue.--It shall be unlawful for any \nperson to knowingly acquire, receive, or otherwise transfer any human \nfetal tissue for valuable consideration if the transfer affects \ninterstate commerce.\n    ``(b) Solicitation or Acceptance of Tissue as Directed Donation for \nUse in Transplantation.--It shall be unlawful for any person to solicit \nor knowingly acquire, receive, or accept a donation of human fetal \ntissue for the purpose of transplantation of such tissue into another \nperson if the donation affects interstate commerce, the tissue will be \nor is obtained pursuant to an induced abortion, and--\n            ``(1) the donation will be or is made pursuant to a promise \n        to the donating individual that the donated tissue will be \n        transplanted into a recipient specified by such individual;\n            ``(2) the donated tissue will be transplanted into a \n        relative of the donating individual; or\n            ``(3) the person who solicits or knowingly acquires, \n        receives, or accepts the donation has provided valuable \n        consideration for the costs associated with such abortion.\n    ``(c) Criminal Penalties for Violations.--\n            ``(1) In general.--Any person who violates subsection (a) \n        or (b) shall be fined in accordance with title 18, United \n        States Code, subject to paragraph (2), or imprisoned for not \n        more than 10 years, or both.\n            ``(2) Penalties applicable to persons receiving \n        consideration.--With respect to the imposition of a fine under \n        paragraph (1), if the person involved violates subsection (a) \n        or (b)(3), a fine shall be imposed in an amount not less than \n        twice the amount of the valuable consideration received.\n    ``(d) Definitions.--For purposes of this section:\n            ``(1) The term `human fetal tissue' has the meaning given \n        such term in section 498A(f).\n            ``(2) The term `interstate commerce' has the meaning given \n        such term in section 201(b) of the Federal Food, Drug, and \n        Cosmetic Act.\n            ``(3) The term `valuable consideration' does not include \n        reasonable payments associated with the transportation, \n        implantation, processing, preservation, quality control, or \n        storage of human fetal tissue.''.\n\nSEC. 4. REPORT BY GENERAL ACCOUNTING OFFICE ON ADEQUACY OF PROTECTIONS.\n\n    (a) In General.--With respect to research on the transplantation of \nhuman fetal tissue for therapeutic purposes, the Comptroller General of \nthe United States shall conduct an audit for the purpose of \ndetermining--\n            (1) whether and to what extent such research conducted or \n        supported by the Secretary of Health and Human Services has \n        been conducted in accordance with section 498A of the Public \n        Health Service Act (as added by section 2 of this Act); and\n            (2) whether and to what extent there have been violations \n        of section 498B of such Act (as added by section 3 of this \n        Act).\n    (b) Report.--Not later than May 19, 1995, the Comptroller General \nof the United States shall complete the audit required in subsection \n(a) and submit to the Congress a report describing the findings made \npursuant to the audit."
}